Found: 22
Select item for more details and to access through your institution.
High levels of c-Met is associated with poor prognosis in glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 517, doi. 10.1007/s11060-015-1723-3
- By:
- Publication type:
- Article
MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 431, doi. 10.1007/s11060-015-1736-y
- By:
- Publication type:
- Article
Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 441, doi. 10.1007/s11060-015-1738-9
- By:
- Publication type:
- Article
A preclinical study demonstrating the efficacy of nilotinib in inhibiting the growth of pediatric high-grade glioma.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 471, doi. 10.1007/s11060-015-1744-y
- By:
- Publication type:
- Article
Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 529, doi. 10.1007/s11060-015-1737-x
- By:
- Publication type:
- Article
Expanding schwannomatosis phenotype.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Deficiency of the protein-tyrosine phosphatase DEP-1/PTPRJ promotes matrix metalloproteinase-9 expression in meningioma cells.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 451, doi. 10.1007/s11060-015-1740-2
- By:
- Publication type:
- Article
Tumor-specific mutations in low-frequency genes affect their functional properties.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 461, doi. 10.1007/s11060-015-1741-1
- By:
- Publication type:
- Article
Clinical characteristics and surgical outcomes of primary spinal paragangliomas.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 539, doi. 10.1007/s11060-015-1742-0
- By:
- Publication type:
- Article
Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 549, doi. 10.1007/s11060-015-1743-z
- By:
- Publication type:
- Article
Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 559, doi. 10.1007/s11060-015-1745-x
- By:
- Publication type:
- Article
Evolution of the Karnosky Performance Status throughout life in glioblastoma patients.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 567, doi. 10.1007/s11060-015-1749-6
- By:
- Publication type:
- Article
Colour contrasting between tissues predicts the resection in 5-aminolevulinic acid-guided surgery of malignant gliomas.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 575, doi. 10.1007/s11060-015-1750-0
- By:
- Publication type:
- Article
Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 585, doi. 10.1007/s11060-015-1751-z
- By:
- Publication type:
- Article
Clinical outcomes with bevacizumab-containing and non-bevacizumab-containing regimens in patients with recurrent glioblastoma from US community practices.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 595, doi. 10.1007/s11060-015-1752-y
- By:
- Publication type:
- Article
MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 481, doi. 10.1007/s11060-015-1753-x
- By:
- Publication type:
- Article
Decreased tumor apparent diffusion coefficient correlates with objective response of pediatric low-grade glioma to bevacizumab.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 491, doi. 10.1007/s11060-015-1754-9
- By:
- Publication type:
- Article
MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 497, doi. 10.1007/s11060-015-1755-8
- By:
- Publication type:
- Article
Significant predictors of patients' uncertainty in primary brain tumors.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 507, doi. 10.1007/s11060-015-1756-7
- By:
- Publication type:
- Article
Eposter Abstracts for AANS/CNS Section on Tumors 11th Biennial Satellite Symposium.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 621, doi. 10.1007/s11060-015-1759-4
- Publication type:
- Article
AANS/CNS Section on Tumors 11th Biennial Satellite Symposium.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 611, doi. 10.1007/s11060-015-1760-y
- Publication type:
- Article
Review of cranial radiotherapy-induced vasculopathy.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 122, n. 3, p. 421, doi. 10.1007/s11060-015-1732-2
- By:
- Publication type:
- Article